🇺🇸 FDA
Pipeline program

A study to compare how the body absorbs different formulations of a new medicine, and how food affects drug absorption, in healthy participants

88545223PSO1001

Phase 1 other active

Quick answer

A study to compare how the body absorbs different formulations of a new medicine, and how food affects drug absorption, in healthy participants for Psoriasis is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Psoriasis
Phase
Phase 1
Modality
other
Status
active

Clinical trials